PMV Pharmaceuticals
Stock Forecast, Prediction & Price Target
PMV Pharmaceuticals (PMVP) stock Price Target by analysts
$6
Potential upside: 279.91%
PMV Pharmaceuticals price prediction
What is PMV Pharmaceuticals stock analysts` prediction?
PMV Pharmaceuticals stock forecast: Based on 1 Wall Street analysts` predicted price targets for PMV Pharmaceuticals in the last 3 months, the avarage price target is $6, with a high forecast of $NaN. The average price target represents a 279.91% change from the last price of $1.58.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
PMV Pharmaceuticals stock Price Target by analysts
Full breakdown of analysts given PMV Pharmaceuticals price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Jeff Jones Oppenheimer | 0% 0/1 | 11 months ago | $6 279.91% upside | $1.75 | StreetInsider | Previous targets (0) |
Kambiz Yazdi Jefferies | 0% 0/1 | over 1 year ago | $5 216.59% upside | $1.58 | TheFly | Previous targets (0) |
Unknown H.C. Wainwright | N/A | almost 3 years ago | $36 2179.49% upside | $10.29 | Benzinga | N/A |
Unknown Oppenheimer | N/A | over 3 years ago | $33 1989.53% upside | $10.24 | Benzinga | N/A |
Unknown Goldman Sachs | N/A | over 3 years ago | $25 1482.97% upside | $14.09 | Benzinga | N/A |
PMV Pharmaceuticals Financial Estimates
PMV Pharmaceuticals Revenue Estimates
PMV Pharmaceuticals EBITDA Estimates
PMV Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $2.34M Low: $2.34M High: $2.34M avg. 0% | Avg: $47.24M Low: $47.24M High: $47.24M avg. 1918.93% | Avg: $99.78M Low: $99.78M High: $99.78M avg. 111.21% |
Net Income
% change YoY
| $-57.84M N/A | $-73.31M -26.74% | $-68.96M 5.94% | Avg: $-82.14M Low: $-94.58M High: $-44.65M avg. -19.12% | Avg: $-87.45M Low: $-93.62M High: $-51.85M avg. -6.46% | Avg: $-68.18M Low: $-68.18M High: $-68.18M avg. 22.03% | Avg: $-41.29M Low: $-41.29M High: $-41.29M avg. 39.43% |
EBITDA
% change YoY
| $-58.29M N/A | $-77.04M -32.15% | $-78.87M -2.38% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.28 N/A | -$1.61 -25.78% | -$1.44 10.55% | Avg: -$1.5 Low: -$1.97 High: -$0.93 avg. -3.93% | Avg: -$1.39 Low: -$1.95 High: -$1.08 avg. 7.34% | Avg: -$1.42 Low: -$1.42 High: -$1.42 avg. -2.40% | Avg: -$0.86 Low: -$0.86 High: -$0.86 avg. 39.43% |
Operating Expenses
% change YoY
| $58.29M N/A | $77.04M 32.15% | $80.13M 4.01% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is PMV Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 8.97% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -94.58M, average is -82.14M and high is -44.65M.
What is PMV Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 507.53% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is PMV Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 10.11% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$1.97, average is -$1.5 and high is $-0.93.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering PMV Pharmaceuticals stock. The most successful analyst is Jeff Jones.